![](/img/cover-not-exists.png)
74 Meaningful symptom benefit with targeted therapy using gefitinibin advanced non small cell lung cancer (NSCLC)
Samuel, J., Berko, E.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81545-4
Date:
July, 2005
File:
PDF, 129 KB
english, 2005